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Abstract. Avian Pseudomonas disease evolves in an acute or chronic form on cage birds and 
involves difficulties concerning establishing an optimal therapeutical conduct. Due to the risk of 
transmission to other individuals, and also to the personnel involved directly in care and treatment of 
ill animals, it is very important to rapidly institute an adequate therapy in order to assure the rapid 
limitation of pseudomonads transmission to humans or other animals. These facts constitute the base 
of the initialization of different studies on some different Pseudomonas spp. strains sensitivity, these 
being isolated from several clinical aviary cases (especially psittacines), in comparison to the different 
groups and types of antibiotics used currently in the treatment scheme of birds. Considering the 
investigations performed, the conclusion is that, even though the latest cephalosporins and 
fluoroquinolons have a maximum efficiency towards some of the strains, these registered also the 
antibiotic resistance phenomenon, in a strong proportion (41,8 to 94,12 % from the tested strains). 
There have been obtained constant results considering streptomycin, azithromycin, amoxicillin, 
associated with clavulanic acid, doxicycline and tetracycline.  
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INTRODUCTION 
 
From opportunist Gram-negative bacteria, Pseudomonas aeruginosa represents  a very 
important concern for pathology, due to its ubiquitary distribution, and also the various and 
numerous mechanisms of pathogenity, which allow it to produce a large gamut of primary and 
secondary infections, with anathomic and clinical manifestations of high diversity in humans 
and animals. The fact that this bacterium is present in the water, soil, on the surface of the 
plants, in the organisms of insects or human one and of different animals species in 
considerable quantities, under the shape of a colony included in a carbohydrates mass, with 
fibrillar aspect, explains why, especially in stress conditions or after the long application of 
antibiotic treatments, this bacterium is rapidly multiplying, determining pathological 
processes in minor resistance spots of different tissues. There has been demonstrated that this 
bacterium possesses several structures or it elaborates during its metabolism numerous 
substances able to produce the deep alteration of the normal functions of the organism 
(tissues). The structures on the surface of the bacterial cell (pili, surface carbohydrates, 
lipopolyglucids from the cell wall) are the main determining agents of virulence. But the 
bacterium elaborates also some toxic substances as: exotoxin A, proteases, lecitinases and 
endotoxins, which determine irreversible lesions in different types of tissues. If it is 
considered the limited possibilities to treat the infections that this bacterial species determines 
in humans and animals, due to a small number of active antibiotics for this bacterium, the 
relative high rate of mutation towards the antibiotic resistance and of rapid selection 
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possibilities for resistant mutants, the result is a precise image considering the causes which 
explain the implications that this bacterium has in pathology field.  
Considering the aspects presented until this point and also the fact that in the birds 
population there are many situations in which Pseudomonas aeruginosa can be incriminated 
on the disease production to cage and volery birds, the investigations concerning the 
morphological properties, the pathogenic potential of isolated Pseudomonas aeruginosa 
strains, and also the prophylactic measures which are implied in this paper, are fully justified. 
In most of the cases, the etiological agent of aviary pseudomonad is Pseudomonas aeruginosa, 
but there have been described also embryos’ mortality and respiratory diseases in birds, 
caused nu Pseudomonas fluorescens and also respiratory infections due to Pseudomonas 
stutzeri. Pseudomonas aeruginosa is representative for the main genus considered in aviary 
pathology, producing systemic infections and localized ones. Pseudomonas spp. infections, 
either systemic or localized, are frequent in numerous species of birds, being either domestic 
or savage, and they produce high losses to intensive aviculture, through their large spreading 
and their high prevalency.  
The behavior of Pseudomonas aeruginosa towards the antibiotic action remains one of 
the main problems, every day being an up-to-date one, in pathology. In this sense, there has 
been proven the natural resistance of this bacterium towards the action of available 
antibiotics, the frequent earning of antibiotic resistance towards the bacterium was initially 
sensitive, and also to the high toxicity of efficient antibioticts for the organisms subjected to 
treatment. The antibiotic activity towards Pseudomonas aeruginosa is in comparison with 
their capacity of penetrating the cell wall, of their resistance to inactivating action of bacterial 
enzymes and the affinity of the antibiotic for some of the cell structures. In turn, Pseudomonas 
aeruginosa can thwart the antibiotic action through one of the following mechanisms: the 
elaboration of some alternative systems which can replace or substitute the one which is 
inhibited; the reduction of target enzyme activity, which keeps its normal structure and the 
substitution of its activity through other metabolic routes; the exclusion of the inhibiting agent 
from the target spotsby reducing the permeability of cell wall or the production of several 
macromolecules on the surface; the distruction of the antibiotic through hydrolysis, the 
substitution of some chemical groups of the antibiotic. The resistance of Pseudomonas 
aeruginosa species towards the antibiotic action has a genetic correspondent; usually, more 
than 95 % of genetic information is contained in the chromosomes and only 1-5 % in 
plasmids. There has also been observed that, generally, there is no full correspondence 
between the “in vitro” sensitivity of Pseudomonas aeruginosa and the one “in vivo”.  
 
MATERIALS AND METHODS 
 
In this study, there have been used 17 strains of Pseudomonas aeruginosa and 12 
strains of Pseudomonas fluorescens, isolated from different species of psittacines, being tested 
the sensitivity towards: nalidixic acid, ampicillin, amoxicillin, amoxicillin associated with 
clavulanic acid, doxicycline, tetracycline, rifampicin, erythromycin, azithromycin, 
streptomycin, gentamicin, kanamycin, cephalothin, cefaclor, cefotaxime, cefoperazone, 
ceftriaxone, enrofloxacine, ciprofloxacine, ofloxacine. 
There has been used the diffusimetric quantitative antibiogram on solid media (Stokes 
method modified by Balş), which involves: 
- obtaining a bacterial culture, after 18 hours, with a concentration of 107 cells/ml; 
- it is poured a quantity of 16 ml of Müeller-Hinton gelose in each Petri plate, 
afterwards the plates being dried for 15-20 minutes in the thermostat; 
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- the surface of the gelose with bacterial culture prepared before is flooded, the excess 
being discarded; 
- the Petri plates are incubated after the inoculation, with half open lid, for 25-30 
minutes; 
- the microcomprimates with antibiotics are distributed afterwards, 6/plate; 
- after 48 hours, the inhibition areas are read, being measured their diameter with the 
slide rule.  
 
RESULTS AND DISCUSSIONS 
 
By comparison analysis of the results obtained after performing the antibiograms, 
there has been observed that the Pseudomonas strains are generally resistant to nalidixic acid 
(inhibition area with an average of 1,48 mm), ampicillin (inhibition area with an average of 
4,58 mm), tetracycline (inhibition area with an average of 1,27 mm) and streptomycin 
(inhibition area with an average of 2,66 mm). There has also been observed the antibiotic 
resistance of some strains to nalidixic acid and tetracycline.  
The maximum sensitivity has been observed to the latest cephalosporins (cefaclor, 
cefotaxime, cefoperazone) and to quinolones (enrofloxacine, ciprofloxacin), in which the 
inhibition areas were of 12 to 14 mm.  
The statistical results of antibiogram interpreting by applying the Balş method are 
presented in Table no. 1. There are considered: 
- resistant strains: the ones with an inhibition area of 0-1 mm; 
- medium sensitivity strains: the ones with an inhibition area of 10-14 mm; 
- maximum sensitivity strains: the ones with an inhibition area of 14-16 mm.  
 
Table no. 1 
The statistical analysis of antibiogram obtained results 
Tested antibiotic 
The average 
inhibition 
area (mm) 
Resistant strains 
(%) 
Medium 
sensitiveness 
strains (%) 
Maximum 
sensitiveness 
strains (%) 
Nalidixic acid 0,48 94,12 0 0 
Ampicillin 4,58 35,29 41,18 11,76 
Amoxicillin 4,18 17,65 35,29 29,41 
Amoxicillin + 
clavulanic acid 13,38 11,76 58,82 29,41 
Doxicycline 10,11 17,65 35,29 35,29 
Tetracycline 9,27 17,65 35,29 29,41 
Rifampycin 13,05 23,53 29,41 35,29 
Erythromycin 6,30 29,41 17,65 11,76 
Azithromycin 13,11 11,76 35,29 29,41 
Streptomycin 14,05 11,76 17,65 58,82 
Gentamicin 9,11 17,65 29,41 11,76 
Kanamycin 6,83 11,76 17,65 29,41 
Cephalothin 7,27 94,12 0 0 
Cefaclor 2,16 64,71 11,76 0 
Cefotaxime 3,12 88.23 0 0 
Cefoperazone 1,16 64,71 29,41 11,76 
Ceftriaxone 2,17 58,82 11,76 0 
Enrofloxacin 3,14 70,59 17,65 11,76 
Ciprofloxacin 4,12 41,18 35,29 0 
Ofloxacine 1,19 88,23 11,76 0 
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Considering this interpreting, we observed that the maximum efficiency was obtained 
with the latest cephalosporins, and from quinolones, there can be used in therapy 
enrofloxacin, ciprofloxacin, although with an average inhibition area of 11,94 mm it has also 
strains with small inhibitions areas. The tetracycline and the aminoglicosids (gentamicin, 
kanamycin, streptomycin) had small inhibition areas in almost all the strains, this being the 
reason for which we do not recommend them in therapy, even using them in association with 
another antibiotics, having a synergic activity.  
Taking into account the obtained results, although the scientific literature recommends 
the usage of cyclines and quinolones, it can be concluded that the most efficient therapy is 
obtained in antibiotic therapy with streptomycin, amoxicillin associated with clavulanic acid, 
rifampycin, doxicycline or tetracycline.  
 
CONCLUSIONS 
 
1. The antibiotics with the most intense action on Pseudomonas strains, tested “in vivo” 
are streptomycin, rifampycin, amoxicillin associated with clavulanic acid, 
azithromycin and doxicycline.  
2. The antibiotics from cephalosporins group or fluoroquinolones group have proven not 
to be efficient in treating the tested Pseudomonas spp. strains.  
3. The antibiotics from β-lactamin and some macrolids (erythromycin) had a reduced 
action on the tested strains. 
4. The highest percentage of resistance to the antibiotic activity has been observed in 
cephalosporins and fluoroquinolones.  
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